Aortic atherosclerosis as an embolic source

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Stroke is the third leading cause of death in several industrial countries and cardiogenic embolism accounts for 15–30 % of ischaemic strokes [1–5]. The diagnosis of a cardioembolic source of stroke is frequently uncertain and relies on the identification of a potential cardiac source of embolism in the absence of significant autochthonous cerebrovascular occlusive disease. In this regard, echocardiography (either transthoracic – TTE or Transoesophageal – TEE) serves as a cornerstone in the evaluation and diagnosis of these patients [6, 7].

Original languageEnglish
Title of host publicationPharmacotherapy in Aortic Disease
PublisherSpringer International Publishing
Pages1-64
Number of pages64
ISBN (Print)9783319095554, 9783319095547
DOIs
Publication statusPublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Aortic atherosclerosis as an embolic source'. Together they form a unique fingerprint.

  • Cite this

    Baldassarre, D., & Pepi, M. (2015). Aortic atherosclerosis as an embolic source. In Pharmacotherapy in Aortic Disease (pp. 1-64). Springer International Publishing. https://doi.org/10.1007/978-3-319-09555-4_1